Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure

T. Barry Levine, Jay N Cohn

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

In 42 patients with moderate-to-severe congestive heart failure (CHF), the acute hemodynamic and neurohumoral response to the converting enzyme inhibitors (CEIs) captopril (CPT) and teprotide were measured. Plasma renin activity (PRA) was elevated and correlated with control plasma norepinephrine (PNE) but not with any of the control hemodynamics. Acutely after CEIs, significant (p < 0.001) decreases in right atrial pressure, pulmonary artery pressure (PAP), capillary wedge pressure (PCWP), mean arterial pressure (MAP), total systemic vascular resistance (SVR), pulmonary vascular resistance (PVR), and heart rate (HR, p < 0.002), as well as an increase in cardiac index (p < 0.001), were observed. Control PRA correlated with the degree of hemodynamic change for PAP (r = -0.64), PCWP (r = -0.60), MAP (r = -0.66), SVR (r = -0.61), and PVR (r = -0.61). Long-term CPT therapy in 12 of these patients resulted in symptomatic improvement and a marked increase in exercise tolerance (7.4 to 10.4 minutes, p < 0.009). These data suggest that CEIs effect beneficial acute hemodynamic improvements in depressed left ventricular function, leading to substantial reduction in disabling symptomatology and augmentation of exercise capacity in patients with stable severe CHF. Thus, CPT appears to provide well-tolerated, effective long-term ambulatory vasodilator therapy for advanced cardiac dysfunction.

Original languageEnglish (US)
Pages (from-to)1159-1164
Number of pages6
JournalAmerican Heart Journal
Volume104
Issue number5 PART 2
DOIs
StatePublished - Nov 1982

Fingerprint Dive into the research topics of 'Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure'. Together they form a unique fingerprint.

Cite this